Novozymes A/S B buy RudolfL
Start price
26.01.20
/
50%
€46.87
Target price
13.08.20
€53.00
Performance (%)
5.33%
End price
13.08.20
€49.37
Summary
This prediction ended on 13.08.20 with a price of €49.37. With a performance of 5.33%, the BUY prediction by RudolfL for Novozymes A/S B closed with a slight gain. A total of €0.70 was paid as dividends for this prediction. RudolfL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novozymes A/S B | 1.153% | 1.153% | 19.464% | -6.742% |
iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
Buy mit Kursziel 53,0
In the thread Trading Novozymes A/s Nam. B
Buy beendet
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€55.52
11.09.20
11.09.20
€63.00
04.11.21
04.11.21
18.70%
05.11.21
05.11.21
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected